Global contraceptive drugs market projected to grow to USD 40.08 billion by 2033

From GlobeNewswire: 2024-06-25 02:00:00

The Global Contraceptive Drugs Market is projected to grow from USD 18.53 billion in 2023 to USD 40.08 billion by 2033, with a compound annual growth rate (CAGR) of 8.02%. Contraceptive drugs aim to prevent unwanted pregnancies, control birth rates, and reduce the risk of sexually transmitted diseases (STDs) among fertile women aged 15 to 44. The market for contraceptives is expanding due to increasing awareness of sexual health and advancements in contraceptive devices.

The oral segment dominates the contraceptive drugs market, with oral contraceptives being preferred for affordability and therapeutic benefits over other forms of contraception. Retail pharmacies hold the largest revenue share in the market, responding to the public’s demand for accessible contraceptive options. North America leads the market, with advanced healthcare infrastructure, government support, and widespread availability of contraceptives.

Asia Pacific is forecasted to experience the fastest growth in the contraceptive drugs market as awareness of contraceptives increases, and governments focus on family planning initiatives. Major players in the market include Allergan, Bayer AG, Pfizer Inc., among others. Recent developments in July 2023 include the FDA approval of Perrigo’s Opill, the first over-the-counter birth control pill in the US, enhancing access to contraception and increasing effectiveness.

Spherical Insights & Consulting offers comprehensive market research and analysis on the global contraceptive drugs market, providing insights on product offerings, business strategies, market share, and SWOT analysis for key companies. Segment analysis includes product categories, distribution channels, and regional forecasts up to 2033. For more information and detailed reports, visit sphericalinsights.com.



Read more at GlobeNewswire: Global Contraceptive Drugs Market Size To Worth USD 40.08